Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for AstraZeneca, dated January 7, 2000.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.

Published Date:   January 7, 2000

Company Name:     AstraZeneca

Address:          1800 Concord Pike
                  Wilmington, DE 19850

Main Telephone
 Number:          302/886-3000

Internet Home
 Page Address
  (URL)           www.astrazeneca-us.com

Chief Executive
 Officer:         Tom McKillop

Chief Financial
 Officer:         Jon Symonds

Investor Relations
 Contact:         Ed Seage
 Business number: 302/886-4065
 E-mail address:  edward.seage@zcswilm.zeneca.com

Public Relations
 Contact:         Rachel Bloom
 Business number: 302/886-7858
 E-mail address:  rachel.bloom@astrazeneca.com

Industry:         Pharmaceutical

Trading Symbol/
 Exchange:        NYSE:AZN


Company description: AstraZeneca (NYSE NYSE

See: New York Stock Exchange
:AZN AZN Asian ) is a major international healthcare business engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services.

It is one of the top five pharmaceutical companies in the world with healthcare sales of $13 billion and leading positions in sales of gastrointestinal, oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors.

on·col·o·gy
n.
, anesthesia anesthesia (ănĭsthē`zhə) [Gr.,=insensibility], loss of sensation, especially that of pain, induced by drugs, especially as a means of facilitating safe surgical procedures.  including pain management, cardiovascular, central nervous system (CNS See Continuous net settlement.

CNS

See continuous net settlement (CNS).
) and respiratory products. In the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , AstraZeneca is a $7.2 billion healthcare business with approximately 11,000 employees.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 7, 2000
Words:203
Previous Article:Corporate Profile for Amazing Media, Inc., dated Jan. 7.
Next Article:Corporate Profile for Jabil Circuit, Inc., dated Jan. 7, 2000.
Topics:



Related Articles
AstraZeneca Merger Closing Timetable and Revised Dividend Payment Dates.
IMS HEALTH Strategic Technologies Signs AstraZeneca Operations in Italy for its Pharbase and Premiere Pharmaceutical Relationship Management...
ASGE and AstraZeneca Announce Partnership to Further GI Clinical Research through CORI.
Astrazeneca Selects Autonomy's Technology to Assist in Global Drug Development and Product Delivery.
AstraZeneca Selects Autonomy's Technology to Assist in Global Drug Development and Product Delivery.
AstraZeneca Licenses Silicon Genetics' Gene Expression Enterprise Solution.
Dyax Announces Collaboration With AstraZeneca On Antibody Discovery and Optimization.
Finding the right chemistry: Sarah Harrison's formula for success. (From The Corner Office).
Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression.
A second cholesterol drug poses hazards, may spawn suits.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles